Department of Applied Chemistry, Oita University, 700 Dannoharu, Oita 870-1192, Japan.
Acta Biomater. 2012 Feb;8(2):653-8. doi: 10.1016/j.actbio.2011.09.023. Epub 2011 Sep 24.
Oral administration of biomolecular drugs such as peptides, proteins, and DNA is an attractive delivery method because of the safety and convenience of delivery in contrast to injection administration. However, oral delivery of biomolecules has several potential barriers such as enzymatic degradation in the gastrointestinal tract and low permeability across an intestinal membrane. In this study, we proposed an intestinal patch system that included surfactant-coated insulin for oral delivery. The intestinal patches, which have mucoadhesive and drug-impermeable layers, induced sustained unidirectional insulin release toward intestinal mucosa and inhibition of insulin leakage from the patches. Moreover, the surfactant-coated insulin, which has high compatibility with cell membranes, enhanced insulin transport across the intestinal membrane. This study demonstrates that the intestinal patches might improve protein permeability in the intestinal mucosa, thereby offering an innovative therapeutic strategy.
口服生物分子药物,如肽、蛋白质和 DNA,是一种有吸引力的给药方法,因为与注射给药相比,其具有安全性和便利性。然而,生物分子的口服给药存在几种潜在的障碍,如胃肠道中的酶降解和肠道膜的低通透性。在本研究中,我们提出了一种包含表面活性剂包被胰岛素的肠道贴片系统,用于口服给药。该肠道贴片具有粘膜附着性和药物不可渗透性层,可诱导胰岛素向肠道粘膜的持续单向释放,并抑制胰岛素从贴片泄漏。此外,具有高细胞膜相容性的表面活性剂包被胰岛素,可增强胰岛素穿过肠道膜的转运。本研究表明,肠道贴片可能改善肠道粘膜中蛋白质的通透性,从而提供一种创新的治疗策略。